Absci Corp (ABSI) stock saw a decline, ending the day at $4 which represents a decrease of $-0.17 or -4.08% from the prior close of $4.17. The stock opened at $4.16 and touched a low of $3.92 during ...

The Stargate Project, a $500B initiative focused on artificial intelligence, lifts AI-driven biotech stocks and an unlikely ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

AstraZeneca has unveiled plans to invest around $570 million in Canada and add around 700 new jobs, describing the county as ...

Equities research analysts at Needham & Company LLC assumed coverage on shares of Absci (NASDAQ:ABSI – Get Free Report) in a ...

According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...

"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...

Abbott Laboratories ABT reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11 ...

Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...

Charting, Price Performance, News & Related Contracts.

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

The hospitality software company reported adjusted earnings of 38 cents per share, beating Wall Street’s call for 31 cents.